← Back to Search

Behavioral Intervention

Component 2: Diet Quality for Weight Loss

N/A
Waitlist Available
Led By Kathryn M Ross, PhD, MPH
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Age ≥ 18 years
* BMI ≥ 30.0 kg/m2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily throughout the study period (up to 17 weeks)
Awards & highlights

Summary

Self-monitoring (of weight, intake, and activity) is a core component in evidence-based lifestyle interventions for obesity. Research has shown that interventionist feedback increases adherence to self-monitoring and improves weight loss outcomes; however, little empirical evidence exists on how this feedback should be provided. This research study aims to optimize the provision of self-monitoring feedback.

Who is the study for?
This trial is for individuals looking to manage obesity through weight loss. Participants should be committed to self-monitoring their diet, physical activity, and weight. Specific eligibility criteria are not provided, but typically include being over a certain age and having a body mass index (BMI) that classifies as obese.
What is being tested?
The study tests how different components like diet quality, goal setting, calorie goals, and physical activity affect the success of self-monitoring in treating obesity. It aims to find the best way to provide feedback that encourages adherence to these components.
What are the potential side effects?
Since this trial focuses on lifestyle interventions rather than medication or surgery, side effects may include muscle soreness from increased physical activity or hunger if adjusting to new dietary restrictions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily throughout the study period (up to 17 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and daily throughout the study period (up to 17 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Weight
Secondary study objectives
Calorie Goal Attainment
Feedback Message Acceptability
Frequency of Self-Monitoring Dietary Intake
+5 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Component 4: Goal SettingExperimental Treatment1 Intervention
Participants will be randomized to either receive or not receive feedback based on weekly goal setting.
Group II: Component 3: Physical Activity Goal AttainmentExperimental Treatment1 Intervention
Participants will be randomized to either receive or not receive feedback based on physical activity goal attainment.
Group III: Component 2: Diet QualityExperimental Treatment1 Intervention
Participants will be randomized to either receive or not receive feedback based on diet quality.
Group IV: Component 1: Calorie Goal AttainmentExperimental Treatment1 Intervention
Participants will be randomized to either receive or not receive feedback based on calorie goal attainment.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,379 Previous Clinical Trials
752,001 Total Patients Enrolled
12 Trials studying Weight Loss
1,237 Patients Enrolled for Weight Loss
Kathryn M Ross, PhD, MPHPrincipal InvestigatorUniversity of Florida
~21 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top